ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Massie, R.J.H.
Right arrow Articles by Robertson, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Massie, R.J.H.
Right arrow Articles by Robertson, C.
Eur Respir J 2001; 17:1195-1200
Copyright ©ERS Journals Ltd 2001

Intron-8 polythymidine sequence in Australasian individuals with CF mutations R117H and R117C

R.J.H. Massie1, N. Poplawski2, B. Wilcken3, J. Goldblatt4, C. Byrnes5 and C. Robertson1

1 Dept of Respiratory Medicine, Royal Children's Hospital, Melbourne, Australia, 2 Dept of Chemical Pathology, Women's and Children's Hospital, North Adelaide, Australia, 3 Royal Alexandra Hospital for Children, Sydney, Australia, 4 Princess Margaret Hospital for Children, Perth, Australia, 5 Starship Children's Hospital, Auckland, New Zealand

CORRESPONDENCE: R.J.H. Massie, Dept of Respiratory Medicine, Royal Children's Hospital, Melbourne, 3052, Australia. Fax: 61 393491289

Keywords: cystic fibrosis, genotype, phenotype, R117H

Received: June 26, 2000
Accepted January 15, 2001

Compound heterozygotes for a severe cystic fibrosis transmembrane conductance regulator (CFTR) mutation and the R117H or R117C mutation (R117H/C) have clinical presentations that vary from classic cystic fibrosis (CF) to an incidental genetic finding.

The aim of this study was to assess the influence of the intron-8 polythymidine sequence (IVS8) on the relationship between genotype and phenotype of individuals with R117H/C.

All individuals with R117H/C known to CF clinics in Australia and New Zealand were retrospectively studied by collecting information on genotype, age, pancreatic status, sweat electrolytes, sputum microbiology and pulmonary function.

Forty-one individuals (39 with R117H and two with R117C), 16 on an IVS8-5T background and 25 on an IVS8-7T background were identified. Twelve individuals presented clinically, four were siblings of known R117H/C compound heterozygotes and 25 were detected by newborn screening. Eleven of 14 of the IVS8-5T group (78%) with sweat chloride results available had sweat Cl>60 mmol·L–1 compared to 5 (20%) of the R117H/7T group (Chi-squared=10.4, p=0.001). Two were pancreatic insufficient, both IVS8-5T. Two IVS8-5T individuals have recently died (aged 43 and 19) and of the 14 surviving IVS8-5T group, 11 (79%) are symptomatic compared to eight (32%) of the IVS8-7T individuals (Chi-squared=6.1, p=0.01).

In conclusion, most individuals with R117H/C on a IVS8-5T background have an elevated sweat chloride and clinical cystic fibrosis, which in some cases is severe. Most individuals with R117H/C on an IVS8-7T background do not have clinical cystic fibrosis but should be followed for the development of clinical disease.




This article has been cited by other articles:


Home page
 PediatricsHome page
A. M. Comeau, F. J. Accurso, T. B. White, P. W. Campbell III, G. Hoffman, R. B. Parad, B. S. Wilfond, M. Rosenfeld, M. K. Sontag, J. Massie, et al.
Guidelines for Implementation of Cystic Fibrosis Newborn Screening Programs: Cystic Fibrosis Foundation Workshop Report
Pediatrics, February 1, 2007; 119(2): e495 - e518.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
V. Scotet, M.-P. Audrezet, M. Roussey, G. Rault, A. Dirou-Prigent, H. Journel, V. Moisan-Petit, V. Storni, and C. Ferec
Immunoreactive Trypsin/DNA Newborn Screening for Cystic Fibrosis: Should the R117H Variant Be Included in CFTR Mutation Panels?
Pediatrics, November 1, 2006; 118(5): e1523 - e1529.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
B. P. O'Sullivan, R. G. Zwerdling, H. L. Dorkin, A. M. Comeau, and R. Parad
Early Pulmonary Manifestation of Cystic Fibrosis in Children With the {Delta}F508/R117H-7T Genotype
Pediatrics, September 1, 2006; 118(3): 1260 - 1265.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Millson, G. Pont-Kingdon, S. Page, and E. Lyon
Direct Molecular Haplotyping of the IVS-8 Poly(TG) and PolyT Repeat Tracts in the Cystic Fibrosis Gene by Melting Curve Analysis of Hybridization Probes
Clin. Chem., September 1, 2005; 51(9): 1619 - 1623.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Sebastian, S. G. Spitzer, L. E. Grosso, J. Amos, F. V. Schaefer, E. Lyon, D. J. Wolff, A. Hajianpour, A. K. Taylor, A. Millson, et al.
Multicenter Characterization and Validation of the Intron-8 Poly(T) Tract (IVS8-T) Status in 25 Coriell Cell Repository Cystic Fibrosis Reference Cell Lines for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutation Assays
Clin. Chem., January 1, 2004; 50(1): 251 - 254.
[Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
L Curnow, R Savarirayan, and J Massie
Genetic counselling after carrier detection by newborn screening when one parent carries {Delta}F508 and the other R117H
Arch. Dis. Child., October 1, 2003; 88(10): 886 - 888.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the European Respiratory Society.